Senzime AB (SEZI)

Currency in SEK
3.9750
-0.0200(-0.50%)
Closed·
SEZI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.90004.0000
52 wk Range
3.54506.9500
Key Statistics
Prev. Close
3.995
Open
3.945
Day's Range
3.9-4
52 wk Range
3.545-6.95
Volume
109.66K
Average Volume (3m)
167.4K
1-Year Change
-40.0452%
Book Value / Share
1.68
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SEZI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Senzime AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Senzime AB Earnings Call Summary for Q2/2025

  • Senzime reports 90% sales growth in Q2 2025, with U.S. market now representing 72% of total business
  • Gross margin reaches 61.7%, EBITDA improves by 23%, and installed base of TETRAGRAPH units exceeds 4,100
  • Company maintains annual guidance, plans price adjustments to offset tariffs, and aims to expand into pediatric monitoring
  • CEO emphasizes 'hyper-growth phase' and commitment to global accessibility of advanced technology
  • Analysts forecast 90% sales growth for FY2025, though profitability not expected this year
Last Updated: 07/18/2025, 09:00 PM
Read Full Transcript

Earnings

Latest Release
Jul 16, 2026
EPS / Forecast
-0.14 / -0.08
Revenue / Forecast
24.7M / 31.1M
EPS Revisions
Last 90 days

SEZI Income Statement

Compare SEZI to Peers and Sector

Metrics to compare
SEZI
Peers
Sector
Relationship
P/E Ratio
−5.6x152.2x−0.4x
PEG Ratio
−0.210.850.00
Price/Book
2.4x2.1x2.6x
Price / LTM Sales
6.1x2.1x3.1x
Upside (Analyst Target)
164.2%0.0%47.8%
Fair Value Upside
Unlock1.6%6.2%Unlock

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue’s opposition to carrying an alternating electrical current. It also provides additional products, including CliniSenz Analyzer and OnZurf Probe. The company has a strategic connectivity and licensing agreement with Masimo that grants Senzime the rights to use some of Masimo’s intellectual property; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.97M8.25%51.57M
Other Institutional Investors
83.04M52.82%330.09M
Public Companies & Retail Investors
61.20M38.93%243.27M
Total
157.22M100.00%624.93M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Crafoord Foundation16.47%25,896,551102,939
Segulah Venture AB10.09%15,870,27163,084

People Also Watch

39.16
HNSA
-2.97%
1.578
ONCO
+0.51%
183.80
BTSb
+5.39%
134.40
CTTS
-2.04%
15.0
ITAB
+0.67%

FAQ

What Is the Senzime (SEZI) Stock Price Today?

The Senzime stock price today is 3.9750 SEK.

What Stock Exchange Does Senzime Trade On?

Senzime is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Senzime?

The stock symbol for Senzime is "SEZI."

What Is the Senzime Market Cap?

As of today, Senzime market cap is 624.9300M SEK.

What Is Senzime's Earnings Per Share (TTM)?

The Senzime EPS (TTM) is -0.7145.

When Is the Next Senzime Earnings Date?

Senzime will release its next earnings report on Oct 29, 2026.

From a Technical Analysis Perspective, Is SEZI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Senzime Stock Split?

Senzime has split 7 times.

How Many Employees Does Senzime Have?

Senzime has 59 employees.

What is the current trading status of Senzime (SEZI)?

As of Aug 15, 2026, Senzime (SEZI) is trading at a price of 3.9750 SEK, with a previous close of 3.9950 SEK. The stock has fluctuated within a day range of 3.9000 SEK to 4.0000 SEK, while its 52-week range spans from 3.5450 SEK to 6.9500 SEK.

What Is Senzime (SEZI) Price Target According to Analysts?

The average 12-month price target for Senzime is 10.5000 SEK, with a high estimate of 10.5 SEK and a low estimate of 10.5 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +164.15% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.